AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

TRACSIS PLC

Share Issue/Capital Change Mar 2, 2020

7982_rns_2020-03-02_12a456a6-51a2-41ba-bd14-4db92e4c8825.html

Share Issue/Capital Change

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 5605E

Tracsis PLC

02 March 2020

Tracsis plc

("Tracsis" or the "Company")

Listing Application

Tracsis hereby provides notification that application has been made to the London Stock Exchange for the blocklisting of 156,582 ordinary shares of 0.4p each ("Blocklisting Shares"), and admission of the Blocklisting Shares is expected to occur on 6 March 2020.

The Blocklisting Shares will be issued from time to time pursuant to the exercise of employee share option under the following scheme, up to the numbers stated below and as per the performance metrics and vesting schedules attached to the scheme:

2019 Non-EMI Staff LTIP 156,582

The Company will make six-monthly announcements of the utilisation of the Block Admission, in line with its obligations under AIM Rule 29.

At the time of this application, Tracsis has 28,852,751 Ordinary Shares in issue.

Enquiries:

Tracsis plc                                                                                                   Tel: 0845 125 9162

Chris Barnes, CEO

Max Cawthra, CFO

finnCap Ltd                                                                                                 Tel: 020 7220 0500

Christopher Raggett/Scott Mathieson, Corporate Finance

Andrew Burdis, Corporate Broking

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

ALSTPMFTMTBTBMM

Talk to a Data Expert

Have a question? We'll get back to you promptly.